Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 3001
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
52000
I didnt suggest AXON is a better investment
sox0407
12/17/2018 3:16:18 PM
51999
good point Drano For this reasons most of the P3
(1)
aragon1959
12/17/2018 3:09:06 PM
51998
It's the same BS as always. Good news is met with
(6)
scgmck1
12/17/2018 3:02:02 PM
51997
All the while as our company accomplishes ever
(6)
Popperian
12/17/2018 2:43:20 PM
51996
Imagine someone saying "you have a 75% chance of
(5)
Drano
12/17/2018 2:42:27 PM
51995
I would imagine that filling the Phase 3 trial
smokenhot
12/17/2018 2:32:22 PM
51994
"Selective amnesia" -- they forget it because
(1)
Drano
12/17/2018 2:16:43 PM
51993
Seems the swamp easily forgets
BooDog
12/17/2018 2:07:48 PM
51992
Having those contracts in place means that they
(3)
Drano
12/17/2018 1:50:00 PM
51991
-Contracts with Evonik and CoreRx for the
(5)
Chemdeps
12/17/2018 1:41:19 PM
51989
Put a Market buy order in for 15000 shares and
Jimmyboy
12/17/2018 1:23:13 PM
51988
They would just pay the money to get out of the
zdubble17
12/17/2018 1:10:06 PM
51987
Interesting...
Commando911
12/17/2018 12:59:03 PM
51986
More like its important for IPIX shareholders
Trading Pro Broker
12/17/2018 12:51:25 PM
51985
Question for board...does the agreement with the
Commando911
12/17/2018 12:26:44 PM
51984
Partnership with big pharma followed by uplisting
(5)
AlanC
12/17/2018 11:19:33 AM
51983
Wow. Glad I didnt bite at 0.17. People mist be
Squar
12/17/2018 11:17:43 AM
51982
Yes Leo going globally on this one. Unmet need
williamsc
12/17/2018 11:06:51 AM
51981
Rekindling some EU contacts
BooDog
12/17/2018 11:04:47 AM
51980
We got the phase3 go ahead. We are looking at
(3)
williamsc
12/17/2018 11:04:33 AM
51979
I think we would know about a partner within
Squar
12/17/2018 10:57:50 AM
51978
Volume too low
Jimmyboy
12/17/2018 10:40:08 AM
51977
Agreed.......with Dr.Mennon leaving or asked to
(4)
tryz
12/17/2018 10:35:42 AM
51976
I'm thinking we'll see more news either today or
(5)
BooDog
12/17/2018 10:05:33 AM
51975
I've heard no discussion yet of where the funds
(6)
scgmck1
12/17/2018 10:01:09 AM
51974
Trying to decide what to do this morning with
Squar
12/17/2018 9:47:54 AM
51973
Depends on the offer.
Trading Pro Broker
12/17/2018 9:33:53 AM
51972
Well, it looks TheDane is right. Prurisol was
Squar
12/17/2018 9:33:07 AM
51971
What I find most interesting is that the proposed
(6)
Ultimate
12/17/2018 9:28:22 AM
51970
Who knows, P is out the window, and B is going to
Commando911
12/17/2018 9:20:59 AM
51968
I don't believe P was thought to be a long shot
(1)
Squar
12/17/2018 9:17:11 AM
51967
Doubt any sell out happens. Partnerships has
(1)
Jimmyboy
12/17/2018 9:14:28 AM
51966
Expect a full court press by the minions of the
(3)
AlanC
12/17/2018 9:13:15 AM
51965
Agreed, P was a long shot. Everyone here has
Jimmyboy
12/17/2018 9:08:37 AM
51964
Any other 8-Ks today? Anyone?
ThePorchPirate
12/17/2018 9:05:07 AM
51963
Well now that we know all the trial results all
(1)
Squar
12/17/2018 9:04:18 AM
51962
People resign when their services are no longer
Drano
12/17/2018 9:03:02 AM
51961
I kind of saw this coming, Menon went to 1/2 pay
zdubble17
12/17/2018 9:02:31 AM
51959
Untruth is grounds for deletion. Replies to
(1)
Drano
12/17/2018 8:58:22 AM
51958
The P trial failed which from data presented we
Trading Pro Broker
12/17/2018 8:57:43 AM
51956
There were two 8-Ks filed 12/17. The first was
Squar
12/17/2018 8:55:28 AM
51954
I am guessing this qualifies as a successful EOP
Trading Pro Broker
12/17/2018 8:38:04 AM
51953
I see it now on the 8K
zdubble17
12/17/2018 8:37:24 AM
51950
you are right again agree with you on both as
aragon1959
12/17/2018 8:25:12 AM
51949
It may be that they have the formulation done
(2)
Drano
12/17/2018 8:08:49 AM
51948
you are right Drano They must have this
aragon1959
12/17/2018 8:04:59 AM
51947
Don't you think this means they've got the
(1)
Drano
12/17/2018 7:58:51 AM
51946
Our interactions with the FDA have been highly
(1)
Drano
12/17/2018 7:54:46 AM
51945
Head and Neck cancer is 6th most common It should
(1)
aragon1959
12/17/2018 7:53:30 AM
51944
How many patients and what is duration for phase
Zadie
12/17/2018 7:29:47 AM
Newer
Older
Recent Articles
Jacobs to Announce Q3 2025 Results with Strategic Insights
ZBD Achieves EU EMI License and Partners with ClearBank
Celebrating Community and Sustainability: Gardens for Good Winners
BSTR Miner Launches Innovative XRP Cloud Mining Service
Unlocking Profits with AAS MINER's AI Bitcoin Cloud Mining
Neo Pepe Coin Initiates Grand Giveaway for Community Engagement
TopBuild Expands Portfolio with Progressive Roofing Deal
Neuronetics Welcomes Steven Pfanstiel as CFO—A New Era Begins
S&P Global Partners with Anthropic to Transform Financial Analysis
Maryland Court Decision Strengthens MSP Recovery's Case Against GEICO
SELLAS Advances SLS009 for First-Line AML Following Phase 2 Success
Transformational Leadership Change at Neuronetics Strengthens Vision
Emergent BioSolutions Sets Date for Q2 Financial Call
Plus Therapeutics Advances with REYOBIQ™ in Clinical Trial Results
Iovance Biotherapeutics Enhances Leadership with CFO Appointment
WestKam Gold Corp. Welcomes New Interim CFO and Funding Initiative
Changes to Synthetic Dyes in Ice Cream: Major Industry Impact
ProKidney and FDA Collaboration on Rilparencel Approval Insights
Mark Cuban Spotlights Political Strategies of Zohran Mamdani
Unlock Profits with AAS MINER's Smart Mining Innovation
BriaCell Expands Cancer Research Collaborations with Mayo Clinic
Abeona Therapeutics Expands Access to ZEVASKYN Gene Therapy
Mill Creek Residential Opens Modera St. Paul for New Residents
Nexxen Expands CTV Opportunities Through Partnership with VIDAA
Alidade Capital Expands Leadership in Net Lease Investments
Emergent BioSolutions Plans Q2 Financial Reporting Events
Rhode Island's New Law Shields Homeowners from Bad Contracts
Iovance Biotherapeutics Welcomes Corleen Roche as CFO
Insights on Trade Desk Inc and Other Market Movers Today
Sky Quarry Embarks on Innovative Digital Asset Strategy
Canada Nickel Unveils Promising Mineral Resource Estimates
Westgate Energy's Strategic Advances in Oil Production and Market Growth
Spectral Capital Expands Portfolio with 42 Telecom Acquisition
GIBO Holdings Innovates Monetization for Short-Drama Platforms
Palatin Advances Obesity Research with PL7737: Key Findings
Exciting New Bybit Promotion Offers 20,000 USDT Weekly Rewards
BlackRock Sees Significant Revenue Growth and AUM Increase
Innovative Partnership to Enhance Marine Retail Solutions
Breakthrough Advances in Weight Loss Solutions by Palatin
Western Copper and Gold's Essential ESE Project Update
Coveo's Strategic Moves: Renewing Your Investment Confidence
OSR Holdings Welcomes Dr. Niethammer as New CMO of Vaximm
PSEG To Share Insights on Q2 2025 Financial Performance
GIBO Click Achieves Milestone with DramaFlow Monetization Engine
Freightos Achieves Record Performance in Second Quarter
7-Eleven Unveils Flavorful New Menu for Summer Enjoyment
Mokas Coffee & Eatery Announces Exciting Franchise Plans
Rhode Island's New Law Shields Homebuyers from Unfair Practices
S&P Global and Anthropic Collaborate to Transform Financial Data Access
Eshbal Expands U.S. Market Reach with Strategic Moves